vs

Side-by-side financial comparison of AMERICAN SHARED HOSPITAL SERVICES (AMS) and Magyar Bancorp, Inc. (MGYR). Click either name above to swap in a different company.

Magyar Bancorp, Inc. is the larger business by last-quarter revenue ($8.9M vs $7.7M, roughly 1.1× AMERICAN SHARED HOSPITAL SERVICES). Magyar Bancorp, Inc. runs the higher net margin — 35.4% vs -8.2%, a 43.6% gap on every dollar of revenue. On growth, Magyar Bancorp, Inc. posted the faster year-over-year revenue change (19.0% vs -14.8%). Magyar Bancorp, Inc. produced more free cash flow last quarter ($3.7M vs $-2.7M).

American Shared Hospital Services offers turnkey outsourced solutions for advanced radiotherapy, stereotactic radiosurgery and diagnostic imaging equipment to healthcare facilities. It eliminates high upfront capital costs for hospitals, operates primarily across North America, and also serves Latin America and select Asia-Pacific markets, catering to both public and private hospital segments.

Magyar Bank is a bank based in New Brunswick, New Jersey with branches in Central Jersey.

AMS vs MGYR — Head-to-Head

Bigger by revenue
MGYR
MGYR
1.1× larger
MGYR
$8.9M
$7.7M
AMS
Growing faster (revenue YoY)
MGYR
MGYR
+33.8% gap
MGYR
19.0%
-14.8%
AMS
Higher net margin
MGYR
MGYR
43.6% more per $
MGYR
35.4%
-8.2%
AMS
More free cash flow
MGYR
MGYR
$6.4M more FCF
MGYR
$3.7M
$-2.7M
AMS

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
AMS
AMS
MGYR
MGYR
Revenue
$7.7M
$8.9M
Net Profit
$-631.0K
$3.1M
Gross Margin
11.7%
Operating Margin
-18.1%
48.3%
Net Margin
-8.2%
35.4%
Revenue YoY
-14.8%
19.0%
Net Profit YoY
52.5%
50.4%
EPS (diluted)
$-0.09
$0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMS
AMS
MGYR
MGYR
Q4 25
$7.7M
$8.9M
Q3 25
$7.2M
Q2 25
$7.1M
Q1 25
$6.1M
Q4 24
$9.1M
Q3 24
$7.0M
Q2 24
$7.1M
$7.2M
Q1 24
$5.2M
$7.5M
Net Profit
AMS
AMS
MGYR
MGYR
Q4 25
$-631.0K
$3.1M
Q3 25
$-17.0K
Q2 25
$-280.0K
Q1 25
$-625.0K
Q4 24
$-1.3M
Q3 24
$-207.0K
Q2 24
$3.6M
$1.7M
Q1 24
$119.0K
$1.9M
Gross Margin
AMS
AMS
MGYR
MGYR
Q4 25
11.7%
Q3 25
22.1%
Q2 25
23.1%
Q1 25
15.4%
Q4 24
35.3%
Q3 24
19.6%
Q2 24
35.0%
Q1 24
41.1%
Operating Margin
AMS
AMS
MGYR
MGYR
Q4 25
-18.1%
48.3%
Q3 25
-4.8%
Q2 25
-7.7%
Q1 25
-21.3%
Q4 24
-20.2%
Q3 24
-12.7%
Q2 24
-0.0%
30.5%
Q1 24
-1.6%
32.1%
Net Margin
AMS
AMS
MGYR
MGYR
Q4 25
-8.2%
35.4%
Q3 25
-0.2%
Q2 25
-4.0%
Q1 25
-10.2%
Q4 24
-14.6%
Q3 24
-3.0%
Q2 24
51.0%
23.5%
Q1 24
2.3%
25.1%
EPS (diluted)
AMS
AMS
MGYR
MGYR
Q4 25
$-0.09
$0.50
Q3 25
$0.00
Q2 25
$-0.04
Q1 25
$-0.10
Q4 24
$-0.21
Q3 24
$-0.03
Q2 24
$0.55
$0.27
Q1 24
$0.02
$0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMS
AMS
MGYR
MGYR
Cash + ST InvestmentsLiquidity on hand
$3.5M
$34.1M
Total DebtLower is stronger
$17.4M
$49.1M
Stockholders' EquityBook value
$24.0M
$121.7M
Total Assets
$55.5M
$1.0B
Debt / EquityLower = less leverage
0.72×
0.40×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMS
AMS
MGYR
MGYR
Q4 25
$3.5M
$34.1M
Q3 25
$5.1M
Q2 25
$11.1M
Q1 25
$11.2M
Q4 24
$11.0M
Q3 24
$13.8M
Q2 24
$14.2M
$49.0M
Q1 24
$12.8M
$50.0M
Total Debt
AMS
AMS
MGYR
MGYR
Q4 25
$17.4M
$49.1M
Q3 25
$18.2M
Q2 25
$19.1M
Q1 25
$19.9M
Q4 24
$20.4M
Q3 24
$14.4M
Q2 24
$15.1M
Q1 24
$15.6M
Stockholders' Equity
AMS
AMS
MGYR
MGYR
Q4 25
$24.0M
$121.7M
Q3 25
$24.6M
Q2 25
$24.5M
Q1 25
$24.6M
Q4 24
$25.2M
Q3 24
$26.4M
Q2 24
$26.5M
$109.0M
Q1 24
$22.8M
$107.6M
Total Assets
AMS
AMS
MGYR
MGYR
Q4 25
$55.5M
$1.0B
Q3 25
$59.6M
Q2 25
$63.5M
Q1 25
$63.3M
Q4 24
$60.2M
Q3 24
$63.3M
Q2 24
$60.8M
$944.4M
Q1 24
$50.1M
$928.6M
Debt / Equity
AMS
AMS
MGYR
MGYR
Q4 25
0.72×
0.40×
Q3 25
0.74×
Q2 25
0.78×
Q1 25
0.81×
Q4 24
0.81×
Q3 24
0.54×
Q2 24
0.57×
Q1 24
0.68×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMS
AMS
MGYR
MGYR
Operating Cash FlowLast quarter
$-704.0K
$3.7M
Free Cash FlowOCF − Capex
$-2.7M
$3.7M
FCF MarginFCF / Revenue
-34.8%
41.4%
Capex IntensityCapex / Revenue
25.7%
0.0%
Cash ConversionOCF / Net Profit
1.17×
TTM Free Cash FlowTrailing 4 quarters
$-8.5M
$8.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMS
AMS
MGYR
MGYR
Q4 25
$-704.0K
$3.7M
Q3 25
$1.7M
Q2 25
$-372.0K
Q1 25
$2.5M
Q4 24
$274.0K
Q3 24
$472.0K
Q2 24
$1.3M
$1.7M
Q1 24
$-1.9M
$553.0K
Free Cash Flow
AMS
AMS
MGYR
MGYR
Q4 25
$-2.7M
$3.7M
Q3 25
$-2.0M
Q2 25
$-2.3M
Q1 25
$-1.5M
Q4 24
$-4.4M
Q3 24
$-407.0K
Q2 24
$70.0K
$1.5M
Q1 24
$-3.0M
$428.0K
FCF Margin
AMS
AMS
MGYR
MGYR
Q4 25
-34.8%
41.4%
Q3 25
-28.3%
Q2 25
-32.1%
Q1 25
-24.7%
Q4 24
-48.4%
Q3 24
-5.8%
Q2 24
1.0%
21.5%
Q1 24
-58.4%
5.7%
Capex Intensity
AMS
AMS
MGYR
MGYR
Q4 25
25.7%
0.0%
Q3 25
51.6%
Q2 25
26.9%
Q1 25
65.7%
Q4 24
51.4%
Q3 24
12.6%
Q2 24
17.2%
2.0%
Q1 24
22.7%
1.7%
Cash Conversion
AMS
AMS
MGYR
MGYR
Q4 25
1.17×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.36×
1.00×
Q1 24
-15.67×
0.29×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMS
AMS

Direct Patient Services$4.0M51%
Rental Income From Medical Services$2.7M35%
Pbrt Services$1.2M15%

MGYR
MGYR

Segment breakdown not available.

Related Comparisons